Raisio's Strategic Shift: Selling Plant Protein Business to Valio
February 14, 2025, 4:48 am
In a significant move within the food industry, Raisio, a Finnish food company, has decided to sell its plant protein business to Valio, another Finnish giant in the dairy sector. The deal, valued at €7 million, marks a pivotal moment for both companies as they navigate the evolving landscape of food production and consumption.
Raisio's plant protein business, which includes the well-known Härkis® and Beanit® brands, has struggled financially. In 2024, the business reported net sales of €4.5 million, a slight decline from €5.5 million in 2023. The losses were notable, with a comparable EBIT of -€2.6 million in 2024 and -€3.2 million in 2023. These figures paint a picture of a struggling segment within Raisio's broader portfolio.
The sale agreement encompasses not just the brands but also the fixed assets, including the equipment at the Kauhava factory. This factory has been the heart of Raisio's plant protein production. The deal will also see the transfer of 16 employees to Valio, ensuring job continuity amid the transition. Raisio will continue to lease the factory property, subleasing it to Valio, which indicates a collaborative approach to the transition.
Raisio's CEO has emphasized that this divestment does not signal a retreat from the plant-based food sector. Instead, it is a strategic recalibration. The company remains committed to promoting the food transition and innovating within the plant-based space. Raisio is in the final stages of refining its strategy, with plans to unveil a new direction in March 2025.
Valio, on the other hand, is expanding its horizons. Traditionally a dairy company, Valio is positioning itself as a comprehensive food company. This acquisition is a step towards diversifying its product offerings beyond dairy. Valio's executive leadership sees this as an opportunity to innovate and grow, aligning with a broader trend in the food industry towards plant-based alternatives.
The food landscape is changing. Consumers are increasingly seeking sustainable and healthy options. This shift is not just a trend; it’s a necessity driven by a growing global population and environmental concerns. Valio's strategy reflects this reality, as it aims to integrate plant-based and animal-based foods, along with cellular agriculture, into its product lineup.
Raisio's journey with the Härkis® and Beanit® brands began in 2021 when it acquired Verso Food Oy. At that time, plant proteins were seen as a key area for growth. However, the market dynamics have shifted, and Raisio's decision to divest indicates a reevaluation of its priorities. The company is not abandoning plant-based foods; rather, it is choosing to focus on areas where it can achieve greater success.
The partnership between Valio and the Swedish biotech company Melt&Marble is another indication of the industry's direction. This collaboration aims to develop fermented fats for plant-based foods, enhancing the sensory experience of animal-free alternatives. Such innovations are crucial as consumers demand more from plant-based products, seeking flavors and textures that rival traditional options.
The sale of Raisio's plant protein business is a microcosm of a larger trend in the food industry. Companies are reassessing their portfolios, focusing on core competencies while exploring new avenues for growth. The landscape is competitive, and adaptability is key. As consumer preferences evolve, companies must be agile, ready to pivot in response to market demands.
Raisio's commitment to health and sustainability remains intact. The company has a strong reputation for producing heart-healthy products, and its other brands, like Benecol® and Elovena®, continue to resonate with health-conscious consumers. This strategic shift allows Raisio to concentrate on its strengths while leaving the plant protein segment in capable hands.
Valio's acquisition is not just about expanding its product range; it’s about embracing a future where plant-based foods play a significant role. The integration of plant proteins into Valio's offerings aligns with consumer trends towards healthier and more sustainable eating habits. This move positions Valio as a forward-thinking player in the food industry, ready to meet the challenges of tomorrow.
In conclusion, the sale of Raisio's plant protein business to Valio is a strategic maneuver reflecting the complexities of the modern food industry. Both companies are navigating a landscape marked by change and opportunity. Raisio is refining its focus, while Valio is expanding its horizons. Together, they are contributing to a food system that is increasingly diverse, sustainable, and responsive to consumer needs. The future of food is here, and it’s a blend of tradition and innovation, plant and animal, health and sustainability.
Raisio's plant protein business, which includes the well-known Härkis® and Beanit® brands, has struggled financially. In 2024, the business reported net sales of €4.5 million, a slight decline from €5.5 million in 2023. The losses were notable, with a comparable EBIT of -€2.6 million in 2024 and -€3.2 million in 2023. These figures paint a picture of a struggling segment within Raisio's broader portfolio.
The sale agreement encompasses not just the brands but also the fixed assets, including the equipment at the Kauhava factory. This factory has been the heart of Raisio's plant protein production. The deal will also see the transfer of 16 employees to Valio, ensuring job continuity amid the transition. Raisio will continue to lease the factory property, subleasing it to Valio, which indicates a collaborative approach to the transition.
Raisio's CEO has emphasized that this divestment does not signal a retreat from the plant-based food sector. Instead, it is a strategic recalibration. The company remains committed to promoting the food transition and innovating within the plant-based space. Raisio is in the final stages of refining its strategy, with plans to unveil a new direction in March 2025.
Valio, on the other hand, is expanding its horizons. Traditionally a dairy company, Valio is positioning itself as a comprehensive food company. This acquisition is a step towards diversifying its product offerings beyond dairy. Valio's executive leadership sees this as an opportunity to innovate and grow, aligning with a broader trend in the food industry towards plant-based alternatives.
The food landscape is changing. Consumers are increasingly seeking sustainable and healthy options. This shift is not just a trend; it’s a necessity driven by a growing global population and environmental concerns. Valio's strategy reflects this reality, as it aims to integrate plant-based and animal-based foods, along with cellular agriculture, into its product lineup.
Raisio's journey with the Härkis® and Beanit® brands began in 2021 when it acquired Verso Food Oy. At that time, plant proteins were seen as a key area for growth. However, the market dynamics have shifted, and Raisio's decision to divest indicates a reevaluation of its priorities. The company is not abandoning plant-based foods; rather, it is choosing to focus on areas where it can achieve greater success.
The partnership between Valio and the Swedish biotech company Melt&Marble is another indication of the industry's direction. This collaboration aims to develop fermented fats for plant-based foods, enhancing the sensory experience of animal-free alternatives. Such innovations are crucial as consumers demand more from plant-based products, seeking flavors and textures that rival traditional options.
The sale of Raisio's plant protein business is a microcosm of a larger trend in the food industry. Companies are reassessing their portfolios, focusing on core competencies while exploring new avenues for growth. The landscape is competitive, and adaptability is key. As consumer preferences evolve, companies must be agile, ready to pivot in response to market demands.
Raisio's commitment to health and sustainability remains intact. The company has a strong reputation for producing heart-healthy products, and its other brands, like Benecol® and Elovena®, continue to resonate with health-conscious consumers. This strategic shift allows Raisio to concentrate on its strengths while leaving the plant protein segment in capable hands.
Valio's acquisition is not just about expanding its product range; it’s about embracing a future where plant-based foods play a significant role. The integration of plant proteins into Valio's offerings aligns with consumer trends towards healthier and more sustainable eating habits. This move positions Valio as a forward-thinking player in the food industry, ready to meet the challenges of tomorrow.
In conclusion, the sale of Raisio's plant protein business to Valio is a strategic maneuver reflecting the complexities of the modern food industry. Both companies are navigating a landscape marked by change and opportunity. Raisio is refining its focus, while Valio is expanding its horizons. Together, they are contributing to a food system that is increasingly diverse, sustainable, and responsive to consumer needs. The future of food is here, and it’s a blend of tradition and innovation, plant and animal, health and sustainability.